ENLIVEN THERAPEUTICS, INC. Other Nonoperating Income (Expense)
ENLIVEN THERAPEUTICS, INC. (ELVN) reported Other Nonoperating Income (Expense) of -$8.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-05
- ENLIVEN THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$8.00K.
- ENLIVEN THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was $0.00.
- ENLIVEN THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $0.00.
- ENLIVEN THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $0.00.
- ENLIVEN THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2025 was -$49.00K.
- ENLIVEN THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2024 was -$2.00K.
- ENLIVEN THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2023 was -$22.00K.
- ENLIVEN THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2022 was $0.00.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.00K 10-Q · filed 2026-08-05 | -$8.00K 10-Q · filed 2026-08-05 | -$8.00K derived: sum of 3 quarters · filed 2026-08-05 | -$8.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | -$2.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | -$2.00K derived: sum of 3 quarters · filed 2026-08-05 | -$49.00K 10-K · filed 2026-03-03 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | -$2.00K derived: sum of 2 quarters · filed 2026-08-05 | -$49.00K 10-Q · filed 2025-11-12 | -$49.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | -$2.00K 10-Q · filed 2026-08-05 | -$49.00K 10-Q · filed 2026-08-05 | -$49.00K derived: sum of 3 quarters · filed 2026-08-05 | -$49.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | -$47.00K 10-Q · filed 2026-05-07 | -$47.00K derived: sum of 2 quarters · filed 2026-05-07 | -$47.00K derived: sum of 3 quarters · filed 2026-05-07 | -$48.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | -$1.00K derived: sum of 3 quarters · filed 2026-03-03 | -$2.00K 10-K · filed 2026-03-03 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | -$1.00K derived: sum of 2 quarters · filed 2025-11-12 | -$2.00K 10-Q · filed 2025-11-12 | -$11.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$1.00K 10-Q · filed 2025-08-13 | -$2.00K 10-Q · filed 2025-08-13 | -$11.00K derived: sum of 3 quarters · filed 2025-08-13 | -$24.00K derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | -$1.00K 10-Q · filed 2025-05-14 | -$10.00K derived: sum of 2 quarters · filed 2025-05-14 | -$23.00K derived: sum of 3 quarters · filed 2025-05-14 | -$23.00K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$22.00K derived: sum of 2 quarters · filed 2025-03-13 | -$22.00K derived: sum of 3 quarters · filed 2025-03-13 | -$22.00K 10-K · filed 2025-03-13 | |||
| 2023-09-30 | -$13.00K 10-Q · filed 2024-11-13 | -$13.00K derived: sum of 2 quarters · filed 2024-11-13 | -$13.00K 10-Q · filed 2024-11-13 | -$13.00K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2024-08-13 | $0.00 derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | $0.00 derived: sum of 3 quarters · filed 2024-05-14 | -$38.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | -$38.00K derived: sum of 3 quarters · filed 2024-03-14 | $0.00 10-K · filed 2024-03-14 | -$97.00K 10-K · filed 2023-02-10 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | -$20.00K 10-Q · filed 2022-10-25 | -$38.00K derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | -$114.00K 10-Q · filed 2022-10-25 | -$151.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$38.00K 10-Q · filed 2022-08-03 | -$94.00K 10-Q · filed 2022-08-03 | -$151.00K derived: sum of 3 quarters · filed 2023-02-10 | -$169.00K derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2022-03-31 | -$56.00K 10-Q · filed 2022-05-06 | -$113.00K derived: sum of 2 quarters · filed 2023-02-10 | -$131.00K derived: sum of 3 quarters · filed 2023-02-10 | -$171.00K derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$75.00K derived: sum of 2 quarters · filed 2023-02-10 | -$115.00K derived: sum of 3 quarters · filed 2023-02-10 | -$175.00K 10-K · filed 2023-02-10 | |||
| 2021-09-30 | -$18.00K 10-Q · filed 2022-10-25 | -$58.00K derived: sum of 2 quarters · filed 2022-10-25 | -$118.00K 10-Q · filed 2022-10-25 | -$201.00K derived: sum of 4 quarters · filed 2022-10-25 | |||
| 2021-06-30 | -$40.00K 10-Q · filed 2022-08-03 | -$100.00K 10-Q · filed 2022-08-03 | -$183.00K derived: sum of 3 quarters · filed 2022-08-03 | -$238.00K derived: sum of 4 quarters · filed 2022-08-03 | |||
| 2021-03-31 | -$60.00K 10-Q · filed 2022-05-06 | -$143.00K derived: sum of 2 quarters · filed 2022-05-06 | -$198.00K derived: sum of 3 quarters · filed 2022-05-06 | -$210.00K derived: sum of 4 quarters · filed 2022-05-06 | |||
| 2020-12-31 | -$83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$138.00K derived: sum of 2 quarters · filed 2022-03-15 | -$150.00K derived: sum of 3 quarters · filed 2022-03-15 | -$145.00K 10-K · filed 2022-03-15 | |||
| 2020-09-30 | -$55.00K 10-Q · filed 2021-11-09 | -$67.00K derived: sum of 2 quarters · filed 2021-11-09 | -$62.00K 10-Q · filed 2021-11-09 | $7.00K derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | -$12.00K 10-Q · filed 2021-08-06 | -$7.00K 10-Q · filed 2021-08-06 | $62.00K derived: sum of 3 quarters · filed 2021-08-06 | $68.00K derived: sum of 4 quarters · filed 2021-08-06 | |||
| 2020-03-31 | $5.00K 10-Q · filed 2021-05-11 | $74.00K derived: sum of 2 quarters · filed 2021-05-11 | $80.00K derived: sum of 3 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $75.00K derived: sum of 2 quarters · filed 2021-03-05 | $75.00K 10-K · filed 2021-03-05 | ||||
| 2019-09-30 | $6.00K 10-Q · filed 2020-11-05 | $6.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |